Cargando…

Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19

Detalles Bibliográficos
Autores principales: Zhou, Zhi-Guo, Jiang, Di-Xuan, Xie, Shu-Min, Zhang, Jing, Zheng, Fang, Peng, Hong, Chen, Xuan, Liu, Ji-Yang, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683873/
https://www.ncbi.nlm.nih.gov/pubmed/33235253
http://dx.doi.org/10.1038/s41392-020-00407-0
_version_ 1783612974112440320
author Zhou, Zhi-Guo
Jiang, Di-Xuan
Xie, Shu-Min
Zhang, Jing
Zheng, Fang
Peng, Hong
Chen, Xuan
Liu, Ji-Yang
Zhang, Lei
author_facet Zhou, Zhi-Guo
Jiang, Di-Xuan
Xie, Shu-Min
Zhang, Jing
Zheng, Fang
Peng, Hong
Chen, Xuan
Liu, Ji-Yang
Zhang, Lei
author_sort Zhou, Zhi-Guo
collection PubMed
description
format Online
Article
Text
id pubmed-7683873
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76838732020-11-24 Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19 Zhou, Zhi-Guo Jiang, Di-Xuan Xie, Shu-Min Zhang, Jing Zheng, Fang Peng, Hong Chen, Xuan Liu, Ji-Yang Zhang, Lei Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-11-24 /pmc/articles/PMC7683873/ /pubmed/33235253 http://dx.doi.org/10.1038/s41392-020-00407-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Zhou, Zhi-Guo
Jiang, Di-Xuan
Xie, Shu-Min
Zhang, Jing
Zheng, Fang
Peng, Hong
Chen, Xuan
Liu, Ji-Yang
Zhang, Lei
Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19
title Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19
title_full Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19
title_fullStr Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19
title_full_unstemmed Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19
title_short Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19
title_sort low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with covid-19
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683873/
https://www.ncbi.nlm.nih.gov/pubmed/33235253
http://dx.doi.org/10.1038/s41392-020-00407-0
work_keys_str_mv AT zhouzhiguo lowdosecorticosteroidcombinedwithimmunoglobulinreversesdeteriorationinseverecaseswithcovid19
AT jiangdixuan lowdosecorticosteroidcombinedwithimmunoglobulinreversesdeteriorationinseverecaseswithcovid19
AT xieshumin lowdosecorticosteroidcombinedwithimmunoglobulinreversesdeteriorationinseverecaseswithcovid19
AT zhangjing lowdosecorticosteroidcombinedwithimmunoglobulinreversesdeteriorationinseverecaseswithcovid19
AT zhengfang lowdosecorticosteroidcombinedwithimmunoglobulinreversesdeteriorationinseverecaseswithcovid19
AT penghong lowdosecorticosteroidcombinedwithimmunoglobulinreversesdeteriorationinseverecaseswithcovid19
AT chenxuan lowdosecorticosteroidcombinedwithimmunoglobulinreversesdeteriorationinseverecaseswithcovid19
AT liujiyang lowdosecorticosteroidcombinedwithimmunoglobulinreversesdeteriorationinseverecaseswithcovid19
AT zhanglei lowdosecorticosteroidcombinedwithimmunoglobulinreversesdeteriorationinseverecaseswithcovid19